Alopecia

The first participant has been enrolled in Eirion Therapeutics’ phase 1 study evaluating the safety of ET-02 for the treatment of androgenic alopecia, the company announced in a press release.

Women who use contraceptive pills may be at a higher risk for frontal fibrosing alopecia, according to a study.

Equillium announced positive topline data from its phase 2, single-dose, proof-of-concept study of EQ101 for the treatment of adults with moderate, severe or very severe alopecia areata, according to a press release.

Soterios Pharma has announced positive topline results from its phase 2 trial evaluating STS-01 for the treatment of mild to moderate alopecia areata, according to a company press release.

The NIH has awarded Emma Guttman-Yassky, MD, PhD, a $6.6 million grant to investigate dupilumab as a treatment for children with alopecia areata, Mount Sinai announced in a press release.

Ritlecitinib was well tolerated and safe when continually used to treat alopecia areata in patients aged 12 years and older, according to a study.

In this Healio exclusive video, Ronda S. Farah, MD, FAAD, talks about a session at this year’s American Academy of Dermatology Annual Meeting on addressing misinformation on social media and tips for dermatologists.

Low-dose oral minoxidil was similarly efficacious as the drug’s topical version in male androgenetic alopecia, according to a study.

Prescribers have expressed an overall positive opinion toward the off-label use of low-dose oral minoxidil for the treatment of androgenetic alopecia, though opinions varied based on years of experience, according to a study.